puromycin aminonucleoside has been researched along with Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fogo, A | 1 |
| Abe, K; Furuyama, T; Obara, K; Saito, T; Sato, H; Yamakage, K; Yoshinaga, K | 1 |
1 review(s) available for puromycin aminonucleoside and Hypertrophy
| Article | Year |
|---|---|
Internephron heterogeneity of growth factors and sclerosis.
Topics: Angiotensin II; Animals; Glomerulosclerosis, Focal Segmental; Growth Substances; Humans; Hypertrophy; Kidney Diseases; Kidney Glomerulus; Nephrectomy; Nephrons; Platelet-Derived Growth Factor; Proteinuria; Puromycin Aminonucleoside; Rats | 1994 |
1 other study(ies) available for puromycin aminonucleoside and Hypertrophy
| Article | Year |
|---|---|
Progression of experimental focal glomerulosclerosis in the spontaneously hypertensive rat.
Topics: Animals; Arteries; Arterioles; Blood Urea Nitrogen; Creatinine; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Hypertension; Hypertrophy; Kidney Glomerulus; Male; Microscopy, Electron; Necrosis; Protamines; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1990 |